Description

Retatrutide is an emerging peptide compound researched across metabolic and weight related pathways. It has attracted significant scientific interest because of its activity across GLP 1, GIP, and glucagon receptor pathways. Research continues to investigate how these interconnected signalling mechanisms may influence glucose regulation, energy metabolism, and body composition within controlled experimental models. Its multi receptor profile makes Retatrutide a notable compound for researchers studying metabolic biology and peptide based signalling. This formulation contains 10mg across 10 vials and is supplied for controlled laboratory research into metabolic pathways, receptor activity, glucose regulation, energy metabolism, and related biological mechanisms.